A bigger ‘biome

With direct-to-consumer products and diagnostics on the market, uBiome Inc. has raised an $83 million series C round to leverage its growing microbiome database and build a therapeutics pipeline.

OS Fund led the round, which also saw participation from existing investors 8VC and Y Combinator, new investor Dentsu Ventures and other undisclosed investors...